Efficacy and safety of amiodarone 100mg versus 200mg for the maintenance of sinus rhythm after cardioversion of atrial fibrillation

Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2007
INTERVENTION: Trade Name: Cordarone X 100 Cordarone X 200 Product Name: Amiodarone/Cordarone X 100/Cordarone X 200 Pharmaceutical Form: Tablet INN or Proposed INN: AMIODARONE HYDROCHLORIDE CAS Number: 19774824 Current Sponsor code: C02.001 Other descriptive name: Cordarone X 100 Cordarone 200 Concentration unit: mg milligram(s) Concentration type: up to Concentration number: 100‐200 CONDITION: Atrial fibrillation PRIMARY OUTCOME: Main Objective: comparing 2 doses of one drug for the maintenance of sinus rhythm after DC cardioversion Primary end point(s): maintenance of sinus rhythma Secondary Objective: comparing 2 doses of one drug with respect to side effects INCLUSION CRITERIA: atrial fibrillation 30 days to year duration Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18‐64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range
Epistemonikos ID: 0906a72815e3bde0463d0b641d3d0885d303b0d1
First added on: Aug 21, 2024